Author | D. Ross Camidge, MD, PhD


A Novel Antibody-Drug Conjugate and Chemotherapy’s Future in Lung Cancer

September 23, 2015

In this interview we discuss a new trial involving the antibody-drug conjugate IMMU-132 as well as the future of chemotherapy in the treatment of lung cancer.

Unexpected N2 Lymph Node Involvement Found During Surgery for Early-Stage NSCLC

April 30, 2009

During investigation of an episode of self-limiting abdominal pain, a 63-year-old Caucasian female never-smoker was found to have an asymptomatic right lower lobe pulmonary mass. A positron-emission tomography/computed tomography (PET/CT) scan revealed the right lower lobe mass to be 25 × 32 mm with a standardized uptake value (SUV) of 10.2, without evidence of hilar or mediastinal lymphadenopathy or of distant metastases.